ProPhase COVID-19 Testing Units Hit Ch. 11 In NJ

By Ben Zigterman · September 22, 2025, 11:35 AM EDT

Biotechnology company ProPhase Labs Inc. put three of its COVID-19 laboratory testing subsidiaries in Chapter 11 bankruptcy Monday in New Jersey with combined liabilities of more than $13 million, saying it...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

Biotechnology company ProPhase Labs Inc. put three of its COVID-19 laboratory testing subsidiaries in Chapter 11 bankruptcy in New Jersey with combined liabilities of more than $13 million, saying it has been underpaid by insurance companies.

Case Number

3:25-bk-19836

Judge

Christine M. Gravelle

Venue

U.S. Bankruptcy Court for the District of New Jersey

Capital Structure

Total Liabilities:

$13.9 million

View Full Scorecard

Documents

Related Sections

Case Information

Case Title

ProPhase Diagnostics, Inc.

Case Number

3:25-bk-19836

Court

New Jersey

Nature of Suit

Date Filed

September 22, 2025

Recent Articles By Ben